Drug delivery to the inner ear using gene therapy

Otolaryngologic Clinics of North America

Volumn 37, Issue 5, 2004, Pages 1091-1108

  Staecker, Hinrich ^a   Brough, Douglas E ^b   Praetorius, Mark ^c   Baker, Kim ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b GENVEC INC   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; AMINOGLYCOSIDE; ANTIOXIDANT; BETA GALACTOSIDASE; BRAIN DERIVED NEUROTROPHIC FACTOR; DIURETIC AGENT; DRUG CARRIER; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GREEN FLUORESCENT PROTEIN; HELIX LOOP HELIX PROTEIN; HERPESVIRUS VECTOR; LIPOSOME; LUCIFERASE; MANGANESE SUPEROXIDE DISMUTASE; NEOMYCIN; NEUROTROPHIN 3; PARVOVIRUS VECTOR; PLASMID DNA; RETROVIRUS VECTOR; SUPEROXIDE DISMUTASE;

ACOUSTIC NERVE FIBER; CELL SURVIVAL; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG MEGADOSE; DRUG SAFETY; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER; HEARING LOSS; HUMAN; INNER EAR; LIVER TOXICITY; NERVE CELL DEGENERATION; NONHUMAN; OXIDATIVE STRESS; REVIEW;

ADMINISTRATION, TOPICAL; ANIMALS; GENE THERAPY; GENETIC VECTORS; HUMANS; ROUND WINDOW; TYMPANIC MEMBRANE;

EID: 5044248841     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otc.2004.05.001     Document Type: Review

References (64)

1. Qian H.S., Channon K., Neplioueva V., Wang Q., Finer M., Tsui L., et al. Improved adenoviral vector for vascular gene therapy: beneficial effects on vascular function and inflammation. Circ Res. 88:(9):2001;911-917
2. Rafii S., Dias S., Meeus S., Hattori K., Ramachandran R., Feurerback F., et al. Infection of endothelium with E1(-)E4(+), but not E1(-)E4(-), adenovirus gene transfer vectors enhances leukocyte adhesion and migration by modulation of ICAM-1, VCAM-1, CD34, and chemokine expression. Circ Res. 88:(9):2001;903-910
3. Ramalingam R., Rafii S., Worgall S., Hackett N.R., Crystal R.G. Induction of endogenous genes following infection of human endothelial cells with an E1(-) E4(+) adenovirus gene transfer vector. J Virol. 73:(12):1999;10183-10190
4. Ramalingam R., Worgall S., Rafii S., Crystal R.G. Downregulation of CXCr gene expression in primary human endothelial cells following infection with E1(-)E4(+) adenovirus gene transfer vectors. Mol Ther. 2:(4):2000;381-386
5. Hobbs W.E., Brough D.E., Kovesdi I., DeLuca N.A. Efficient activation of viral genomes by levels of herpes simplex virus ICP0 insufficient to affect cellular gene expression or cell survival. J Virol. 75:(7):2001;3391-3403
6. Andrews J.L., Kadan M.J., Gorziglia M.I., Kaeldo M., Connelly S. Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII. Mol Ther. 3:(3):2001;329-336
7. Chirmule N., Huges J.V., Gao G.P., Raper S.E., Wilson J.M. Role of E4 in eliciting CD4 T-cell and B-cell responses to adenovirus vectors delivered to murine and nonhuman primate lungs. J Virol. 72:(7):1998;6138-6145
8. Christ M., Louis B., Stoeckel F., Dieterle A., Grave L., Dreyer D., et al. Modulation of the inflammatory properties and hepatoxicity of recombinant adenovirus vectors by the viral E4 gene products. Hum Gene Ther. 11:(3):2000;415-427
9. Gao G.P., Yang Y., Wilson J.M. Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J Virol. 70:(12):1996;8934-8943
10. Gorziglia M.I., Lapcevich C., Roy S., Kang Q., Kadan M., Wu V., et al. Generation of adenovirus vector lacking E1, E2a, E3, and all of E4 except open reading frame 3. J Virol. 73:(7):1999;6048-6055
11. Kanzaki S., Ogawa K., Camper S.A., Raphael Y. Transgene expression in neonatal mouse inner ear explants mediated by first and advanced generation adenovirus vectors. Hear Res. 169:(1-2):2002;112-120
12. Lalwani A.K., Jero J., Mhatre A.N. Developments in cochlear gene therapy. Adv Otorhinolaryngol. 61:2002;28-33
13. Glorioso J.C., DeLuca N.A., Fink D.J. Development and application of herpes simplex virus vectors for human gene therapy. Annu Rev Microbiol. 49:1995;675-710
14. Geller A.l. Herpesviruses: expression of genes in postmitotic brain cells. Curr Opin Genet Devel. 49:1995;675-710
15. Derby M.L., Sena-Esteves M., Breakefield X.O., Corey D.P. Gene transfer into the mammalian inner ear using HSV-1 and vaccinia virus vectors. Hear Res. 134:1999;1-8
16. Fink D.J., DeLuca N.A., Goins W.F., Glorioso J.C. Gene transfer using herpes simplex virus based vectors. Annu Rev Neurosci. 19:1996;265-287
17. Van De Water T.R., Staecker H., Halterman M., Federoff H. Gene therapy in the inner ear. Ann N Y Acad Sci. 884:1999;345-360
18. Lalwani A.K., Han J.J., Walsh B.J., Zolotukhin S., Muzyczka N., et al. Green fluorescent protein as a reporter for gene transfer studies in the cochlea. Hear Res. 114:1997;139-147
19. Raphael Y., Frisancho J.C., Roessler B.J. Adenoviral-mediated gene transfer into guinea pig cochlear cells in vivo. Neurosci Lett. 207:2000;137-141
20. Weiss M.A., Frisancho J.C., Roessler B.J., Raphael Y. Viral-mediated gene transfer in the cochlea. Int J Dev Neurosci. 15:(4/5):1997;577-583
21. Yagi M., Magal E., Sheng Z., Ang K.A., Raphael Y. Hair cell protection from aminoglycoside ototoxicity by adenovirus-mediated overexpression of glial cell lined-derived neurotrophic factor. Hum Gene Ther. 10:1999;813-823
22. Wareing M., Mhatre A.N., Pettis R., Han J.J., Haut T., Pfister M.H.F., et al. Cationic liposome mediated transgene expression in the guinea pig cochlea. Hear Res. 128:1999;61-69
23. Lalwani A.K., Han J.J., Carvalho B.S., Mhatre A.N. The promise of gene therapy in otolaryngology head and neck surgery. Curr Opin Otolaryngol Head Neck Surg. 5:1997;197-202
24. Staecker H., Li D., O'Malley B.W. Jr., Van De Water T.R. Gene expression in the mammalian cochlea: a study of multiple vector systems. Acta Otolaryngol. 121:(2):2001;157-163
25. Smith A.E. Viral vectors in gene therapy. Annu Rev Microbiol. 49:1995;807-839
26. Luebke A.E., Steiger J.D., Hodges B.L., Amalfitano A. A modified adenovirus can transfect cochlear hair cells in vivo without compromising cochlear function. Gene Ther. 8:(10):2001;789-794
27. Ishimoto S., Kawamoto K., Stover T., Kanzaki S., Yamasoba T., Raphael Y. A glucocorticoid reduces adverse effects of adenovirus vectors in the cochlea. Audiol Neurootol. 8:(2):2003;70-79
28. Kawamoto K., Oh S.H., Kanzaki S., Brown N., Raphael Y. The functional and structural outcome of inner ear gene transfer via the vestibular and cochlear fluids in mice. Mol Ther. 4:(6):2001;575-585
29. Praetorius M., Knipper M., Schick B., Tan J., Limberger A., et al. A novel vestibular approach for gene transfer into the inner ear. Audiol Neurootol. 7:(6):2002 Nov-Dec;324-334
30. Praetorius M., Baker K., Weich C.M., Plinkert P.K., Staecker H. Hearing preservation after inner ear gene therapy: the effect of vector and surgical approach. Journal for Oto-Rhino-Laryngology. 65:2003;211-214
31. Luebke A.E., Foster P.K., Muller C.D., Peel A.L. Cochlear function and transgene expression in the guinea pig cochlea, using adenovirus- and adeno-associated virus-directed gene transfer. Hum Gene Ther. 12:(7):2001;773-781
32. Einfeld D.A., Roelvink P.W. Advances towards targetable adenovirus vectors for gene therapy. Curr Opin Mol Ther. 4:(5):2002;444-451
33. Einfield D.A., Schroeder R., Roelvink P.W., Lizonova A., King C.R., Kovesdi I., Wickham T.J. Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions. J Virol. 75:(23):2001;11284-11291
34. Wickham T.J. Ligand-directed targeting of genes to the site of disease. Nat Med. 9:(1):2003;135-139
35. Hodges A.V., Schloffman J., Balkany T. Conservation of residual hearing with cochlear implantation. Am J Otol. 18:(2):1997;179-183
36. Schuknecht H.F. Cochleosacculotomy for Meniere's disease: theory, technique and results. Laryngoscope. 92:(8 Pt 1):1982;853-858
37. Spoendlin H. Biology of the vestibulocochlear nerve. Albert P.W., Ruben R.J. Otologic Medicine and Surgery. vol. 1:1988;117-150 Churchill Livingston, New York
38. Morrison R.S., Kinoshita Y., Johnson M.D., Ghatan S., Ho J.T., Garden G. Neuronal survival and cell death signaling pathways. Adv Exp Med Biol. 513:2002;41-86
39. Stover T., Gong T.W.L., Cho Y., Altschuler R.A., Lomax M.I. Expressions of the GDNF family members and their receptors in the mature rat cochlea. Mol Brain Res. 76:2000;25-35
40. Staecker H., Kopke R., Malgrange B., Lefebvre P., Van De Water T.R. NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells. NeuroReport. 7:(4):1996;889-894
41. Staecker H., Gabaizadeh R., Federoff H., Van De Water T.R. Brain derived neurotrophic factor gene therapy prevents degeneration of spiral ganglion neurons in a mouse model of aminoglycoside ototoxicity. Otolaryngol Head Neck Surg. 119:(1):1998;7-13
42. Kanzaki S., Stover T., Kawamoto K., Prieskorn D.M., Altschuler R.A., Miller J.M., et al. Glial cell line-derived neurotrophic factor and chronic electrical stimulation prevent VIII cranial nerve degeneration following denervation. J Comp Neurol. 454:(3):2002;350-360
43. Incesulu A., Nadol J.B. Jr. Correlation of acoustic threshold measures and spiral ganglion cell survival in severe to profound sensorineural hearing loss: implications for cochlear implantation. Ann Otol Rhinol Laryngol. 107:(11 Pt 1):1998;906-911
44. Nadol J.B. Jr., Young Y.S., Glynn R.J. Survival of spiral ganglion cells in profound sensorineural hearing loss: implications for cochlear implantation. Ann Otol Rhinol Laryngol. 98:(6):1989;411-416
45. Shepherd R.K., Javel E. Electrical stimulation of the auditory nerve I. Correlation of physiological responses with cochlear status. Hear Res. 108:(1-2):1997;112-144
46. Shinohara T., Bredberg G., Ulfendahl M., Pyko I., Olivius N.P., Kaksonen R., et al. Neurotrophic factor intervention restores auditory function in deafened animals. Proc Natl Acad Sci U S A. 99:(3):2002;1657-1660
47. Clerici W.J., Yang L. Direct effects of intraperilymphatic reactive oxygen species generation on cochlear function. Hear Res. 101:1996;14-22
48. Clerici W.J., Hensley K., DiMartino D.L., Butterfield D.A. Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants. Hear Res. 98:1996;116-124
49. Gabaizadeh R., Staecker H., Liu W., Van De Water T.R. BDNF protection of auditory neurons from cisplatin involves changes in intracellular levels of both reactive oxygen species and glutathione. Mol Brain Res. 50:1997;71-78
50. Jiang HY, Talaska AE, Sha SH, Schacht J. Necrotic and apoptotic hair cell death induced by Kanamycin in vivo. Presented at the ARO Midwinter Meeting. 2003.
51. Ohlemiller K.K., Dugan L.L. Elevation of reactive oxygen species following ischemia-reperfusion in mouse cochlea observed in vivo. Audiol Neurootol. 4:1999;219-228
52. Ohlemiller K.K., Wright J.S., Dugan L.L. Early elevation of cochlear reactive oxygen species following noise exposure. Audiol Neurootol. 4:1999;229-236
53. Ohinata Y., Miller J.M., Schacht J. Protection from noise-induced lipid peroxidation and hair cell loss in the cochlea. Brain Res. 966:2003;265-273
54. Hu B.H., Guo W., Wang P.Y., Henderson D., Jiang S.C. Intense noise induced apoptosis in hair cells of guinea pig cochleae. Acta Otolaryngol. 120:2000;19-24
55. Hu B.H., Henderson D., Nicotera T.M. Involvement of apoptosis in progression of cochlear lesion following exposure to intense noise. Hear Res. 166:2002;62-71
56. Hu B, Yang WP, Nicotera T, Henderson D. Mitochondrial functions in apoptotic and necrotic OHCs following exposure to impulse noise. Presented at the Association for Research in Otolaryngology Midwinter Meeting. February 2003, Daytona Beach, FL.
57. Yamasgut D, Jiang HY, Miller JM. Schacht. J. Late emergence of free radicals after noise exposure. Presented at Association for Research in Otolaryngology Midwinter Meeting. February 2003, Daytona Beach, FL.
58. Kopke R.D., Liu W., Gabaizadeh R., Jacono A., Feghali J., Spray D., et al. Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells. Am J Otol. 18:1997;559-571
59. Dehne N., Lautermann A.W.-J.F., Cate A., Rauen U., de Groot H. In vitro effects of hydrogen peroxide on the cochlear neurosensory epithelium of the guinea pig. Hear Res. 143:2000;162-170
60. Bermingham N.A., Hassan B.A., Price S.D., Vollrath M.A., Ben-Arie N., Eatock R.A. Math1: an essential gene for the generation of inner ear hair cells. Science. 284:1999;1837-1841
61. Kopke R.D., Jackson R.L., Li G., Rasmussen M.D., Hoffer M.E., Frenz D.A., et al. Growth factor treatment enhances vestibular hair cell renewal and results in improved vestibular function. Proc Natl Acad Sci U S A. 98:(10):2001;5885-5891
62. Lebfebvre P.P., Malgrange B., Thiry M., Van De Water T.R., Moonen G. Epidermal growth factor upregulates production of supernumerary hair cells in neonatal rat organ of Corti explants. Acta Otolaryngol. 120:2000;142-145
63. Zheng J.L., Gao W.Q. Overexpression of Math1 induces robust production of extra hair cells in postnatal rat inner ears. Nat Neurosci. 3:(6):2000;580-586
64. Kawamoto K., Ishimoto S., Minoda R., Brough D.E., Raphael Y. Math1 gene transfer generates new cochlear hair cells in mature guinea pigs in vivo. J Neurosci. 23:(11):2003;4395-4400